Table 1.
Demographic, Pretreatment, and Treatment Characteristics
| Abstinent Drinking Goal (n=340) | Nonabstinent Drinking Goal (n=340) | p-value | |
|---|---|---|---|
| Demographic Characteristics | |||
| Caucasian (%) | 77 | 83 | 0.07 |
| Currently working (%) | 68 | 78 | <.01 |
| High School Diploma (%) | 93 | 97 | 0.08 |
| Male (%) | 61 | 61 | 0.99 |
| Pretreatment Characteristics | |||
| Nicotine Use (%) | 81 | 77 | 0.29 |
| Cocaine Use (%) | 10 | 7 | 0.99 |
| Any Drug Use (%) | 19 | 17 | 0.48 |
| Heavy drinking days (mean %) | 67 ± 24 | 68 ± 26 | 0.76 |
| Drinks per day (mean) | 8.3 ± 4.5 | 8.0 ± 5.5 | 0.37 |
| Treatment Characteristics | |||
| Acamprosate (%) | 45 | 45 | |
| Naltrexone (%) | 49 | 49 | |
| CBI Counseling (%) | 40 | 40 | |
| Naltrexone Dose (mean) | 89.5 ± 18.6 | 88.2 ± 21.0 | 0.24 |
| Acamprosate Dose (mean) | 2595.1 ± 584.3 | 2526.8 ± 664.3 | 0.06 |
| Adherence to medication (mean %) | 91.1 ± 14.8 | 87.5 ± 20.6 | <.01 |
| Withdrew from treatment (%) | 19 | 17 | 0.24 |
| Days to first drink | 99.9 ± 14.5 | 100.9 ± 14.6 | 0.29 |
| BAC first peak drinking day | 0.29 ± 0.15 | 0.26 ± 0.15 | <.01 |
Chi-square for categorical variables, t-tests for continuous variables